Patient Engagement December 7, 2023
Staffing and the insurgence of artificial intelligence could imperil healthcare and life science work on health equity in 2024.
Health equity will remain in the industry spotlight as healthcare and life sciences executives continue to eye it as a top priority for 2024, according to a new report from Deloitte.
The Deloitte Health Equity Outlook, which surveyed executives and health equity leaders in the medical and life sciences spaces, found that health equity will be a top-10 goal for 80 percent of C-suiters. This further cements the prominence health equity has gained in recent years.
“While most industry leaders we have spoken to see value in ensuring that everyone has access to high-quality health care, realizing a return on the...